2025
Evaluation of a Machine Learning-Guided Strategy for Elevated Lipoprotein(a) Screening in Health Systems
Aminorroaya A, Dhingra L, Oikonomou E, Khera R. Evaluation of a Machine Learning-Guided Strategy for Elevated Lipoprotein(a) Screening in Health Systems. Circulation Genomic And Precision Medicine 2025, 18: e004632. PMID: 39846171, PMCID: PMC11835527, DOI: 10.1161/circgen.124.004632.Peer-Reviewed Original ResearchConceptsYale New Haven Health SystemHealth systemVanderbilt University Medical CenterHealth system electronic health recordUniversity Medical CenterCoronary Artery Risk DevelopmentMulti-Ethnic Study of AtherosclerosisElectronic health recordsMedical CenterUS health systemHealth system patientsAssociated with significantly higher oddsMulti-Ethnic StudyUS-based cohortStudy of atherosclerosisSignificantly higher oddsHealth recordsUK BiobankAtherosclerosis RiskRisk DevelopmentHigher oddsElevated Lp(aUniversal screeningSystem patientsStudy cohort
2023
Obesity and Overweight: Probing Causes, Consequences, and Novel Therapeutic Approaches Through the American Heart Association's Strategically Focused Research Network
Clark J, Garvey W, Niswender K, Schmidt A, Ahima R, Aleman J, Battarbee A, Beckman J, Bennett W, Brown N, Chandler‐Laney P, Cox N, Goldberg I, Habegger K, Harper L, Hasty A, Hidalgo B, Kim S, Locher J, Luther J, Maruthur N, Miller E, Sevick M, Wells Q. Obesity and Overweight: Probing Causes, Consequences, and Novel Therapeutic Approaches Through the American Heart Association's Strategically Focused Research Network. Journal Of The American Heart Association 2023, 12: e027693. PMID: 36752232, PMCID: PMC10111504, DOI: 10.1161/jaha.122.027693.Peer-Reviewed Original ResearchConceptsAmerican Heart AssociationHeart AssociationWeight loss interventionNovel therapeutic approachesVanderbilt University Medical CenterUniversity Medical CenterEffective therapeutic interventionsField of obesityResearch NetworkLoss interventionClinical trialsWorldwide prevalenceMedical CenterTherapeutic approachesObesityTherapeutic targetAnimal modelsJohns Hopkins University SchoolTherapeutic interventionsIndividual centersNew targetsUniversity of AlabamaOverweightUniversity SchoolIntervention
2021
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19
Schmidt A, Tucker M, Bakouny Z, Labaki C, Hsu C, Shyr Y, Armstrong A, Beer T, Bijjula R, Bilen M, Connell C, Dawsey S, Faller B, Gao X, Gartrell B, Gill D, Gulati S, Halabi S, Hwang C, Joshi M, Khaki A, Menon H, Morris M, Puc M, Russell K, Shah D, Shah N, Sharifi N, Shaya J, Schweizer M, Steinharter J, Wulff-Burchfield E, Xu W, Zhu J, Mishra S, Grivas P, Rini B, Warner J, Zhang T, Choueiri T, Gupta S, McKay R, Desai A, Cohen A, Olszewski A, Bardia A, Daher A, Brown A, Yeh A, Hsiao A, Cheng A, Zhou A, Beeghly-Fadiel A, Morgans A, Jha A, Menendez A, Fazio A, Nizam A, Ramirez A, Kulkarni A, Verma A, Elshoury A, Rivera A, Walden A, Piper-Vallillo A, Cook A, Li A, Cantrell A, Cabal A, Nohria A, Angevine A, Gulati A, Giordano A, Kasi A, Ajmera A, Elkrief A, Kariapper A, Loaiza-Bonilla A, Jayaraj A, Thakkar A, Russ A, Bashir B, Halmos B, Logan B, Wood B, Slawik B, Dixon B, French B, Routy B, Mavromatis B, Hayes-Lattin B, Barrow McCollough B, Fleissner B, Stith B, Wicher C, Schwartz C, Thomson C, Solorzano C, Granada C, Brown C, Hennessy C, Stratton C, Castellano C, Ang C, Mandapakala C, Wang C, Jani C, Su C, Misdary C, Chapman C, McNair C, Lemmon C, Geiger C, Friese C, Su C, McKeown C, Hoppenot C, Low C, Pillainayagam C, Ferrario C, Rock C, Gonzalez Gomez C, Masson C, Mundt D, Addison D, Flora D, Stover D, Kwon D, Hausrath D, Bowles D, Reuben D, Shafer D, Bitterman D, O' Sullivan D, Mahadevan D, Sohal D, Whaley D, Slosky D, Chism D, Hershman D, Doroshow D, Ravindranathan D, Farmakiotis D, Bhutani D, Vinh D, Freeman D, Johnson D, Hatton E, Van Allen E, Griffiths E, Davis E, Nakasone E, Loggers E, Robilotti E, Levine E, Cabebe E, Hsu E, Powell E, Nemecek E, Lau E, Durbin E, Bernicker E, Small E, Cook E, Gillaspie E, Reid E, Papadopoulos E, Tadesse E, Wehbe F, Lyman G, Schwartz G, Nagaraj G, Boland G, Demetri G, Batist G, Gantt Jr. G, Kloecker G, Shaw G, Riely G, Borno H, Saker H, Dzimitrowicz H, Nelson H, Khan H, Shaikh H, Polimera H, Chen J, Stratton J, Acoba J, Patel J, Connors J, Mather J, Henderson J, Dill J, Girard J, Warner J, Graber J, Papenburg J, Altman J, Hawley J, Clement J, Park J, Campian J, Philip J, Deeken J, Riess J, Rosenberg J, Loree J, Senefeld J, Kharofa J, Garcia J, Palmer J, Lewis J, Guido J, Fu J, Wu J, Jiang J, Gainor J, Klamerus J, Steve Lo K, Patel K, de Cardenas K, Vega-Luna K, Goldsmith K, Hansen K, Huber K, Stockerl-Goldstein K, Jeffords K, Hoskins K, Reynolds K, Cerrone K, Cortez K, Enriquez K, Rosen L, Lashley L, Pomerantz L, Smith L, Feldman L, Fecher L, Zubiri L, Liu L, Schapira L, Tachiki L, Weissmann L, Rosenstein L, Wang L, Tomasini M, Abidi M, Khan M, Shah M, Rovito M, Gatti-Mays M, Escobedo M, Alexander M, Bonnen M, Fiala M, Lewis M, Dailey M, Reeves M, Sueyoshi M, Portes M, Salazar M, Mulcahy M, Pasquinelli M, Lustberg M, Fiebach M, Luders M, Galsky M, Weiss M, Clark M, Smits M, Accordino M, Markham M, Gurley M, Thompson M, Bar M, Wagner M, Joyner M, Glover M, Wotman M, Braccioforte M, Marcum M, Seletyn M, Huynh-Le M, Santos Dutra M, Streckfuss M, Akhtari M, Gatson N, Bahadur N, Knox N, Edwin N, Pennell N, Bouganim N, Hafez N, Venepalli N, Williams N, Balanchivadze N, Ohri N, Butt O, Panagiotou O, Serrano O, Bohachek P, Egan P, Shah P, Caimi P, LoRusso P, Weinstein P, Yu P, Lammers P, Nuzzo P, Bindal P, Peddi P, Grover P, Zaman Q, Sica R, Rosovsky R, Elias R, Zon R, Gandhi R, Belenkaya R, Rice R, Buerki R, Herbst R, Mesa R, Lynch R, Nguyen R, Monahan R, Jhawar S, Alimohamed S, Jabbour S, Del Prete S, Mahmood S, Goel S, Revankar S, Matar S, Saif S, Mushtaq S, Wall S, Croessman S, Kligerman S, McWeeney S, Goyal S, Choi S, Brouha S, Taylor S, Vinayak S, Gadgeel S, Blau S, Hallmeyer S, Reid S, Williamson S, Fry S, May S, Berg S, Duda S, Greenland S, Murdock S, Subbiah S, Shah S, Shah S, Van Loon S, Ayre S, Owenby S, Rose S, Ahmad S, Zhang S, Latif T, Bekaii-Saab T, Cronin T, Nonato T, Rhodes T, Carducci T, Halfdanarson T, Sun T, Wise-Draper T, Masters T, Topaloglu U, Koshkin V, Mico V, Karivedu V, Walters W, Miller Jr. W, Li X, Rho Y, Xie Z, Sachs Z. Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19. JAMA Network Open 2021, 4: e2134330. PMID: 34767021, PMCID: PMC8590166, DOI: 10.1001/jamanetworkopen.2021.34330.Peer-Reviewed Original ResearchConceptsAndrogen deprivation therapySARS-CoV-2 infectionProstate cancerPropensity matchingDeprivation therapyCohort studyMalignant neoplasmsEastern Cooperative Oncology Group performance status scoreRole of ADTCOVID-19Androgen deprivation therapy useLarge ongoing clinical trialsPharmacologic androgen deprivation therapyCOVID-19 infection severityAndrogen-targeted therapiesBaseline steroid usePerformance status scorePrimary end pointSecond malignant neoplasmsPrimary malignant neoplasmsMonths of presentationBody mass indexOngoing clinical trialsCOVID-19 treatmentVanderbilt University Medical Center
2019
Developing Customizable Cancer Information Extraction Modules for Pathology Reports Using CLAMP
Soysal E, Warner J, Wang J, Jiang M, Harvey K, Jain S, Dong X, Song H, Siddhanamatha H, Wang L, Dai Q, Chen Q, Du X, Tao C, Yang P, Denny J, Liu H, Xu H. Developing Customizable Cancer Information Extraction Modules for Pathology Reports Using CLAMP. Studies In Health Technology And Informatics 2019, 264: 1041-1045. PMID: 31438083, PMCID: PMC7359882, DOI: 10.3233/shti190383.Peer-Reviewed Original ResearchConceptsElectronic health recordsNLP solutionNatural language processing technologyInformation extraction moduleLanguage processing technologyInformation extraction tasksUser-friendly interfaceBest F-measureInformation extractionExtraction moduleExtraction taskCustomizable modulesNLP systemsF-measureAcademic useHealth recordsComparable performanceProcessing technologyVanderbilt University Medical CenterModuleDiverse typesInformationNLPSubstantial effortSystemDiscovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing
Wu Y, Warner J, Wang L, Jiang M, Xu J, Chen Q, Nian H, Dai Q, Du X, Yang P, Denny J, Liu H, Xu H. Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing. JCO Clinical Cancer Informatics 2019, 3: cci.19.00001. PMID: 31141421, PMCID: PMC6693869, DOI: 10.1200/cci.19.00001.Peer-Reviewed Original ResearchConceptsVanderbilt University Medical CenterCancer survivalMayo ClinicDrug repurposingNoncancer drugsElectronic health record dataCancer registry dataEHR dataClinical trial evaluationOverall cancer survivalUniversity Medical CenterHealth record dataElectronic health recordsTreatment of cancerClinical trialsDrug classesRegistry dataMedical CenterDrug effectsSignificant associationLongitudinal EHRNew indicationsPatientsCancerHealth records
2018
Group Prenatal Care Reduces Risk of Preterm Birth and Low Birth Weight: A Matched Cohort Study
Cunningham SD, Lewis JB, Shebl FM, Boyd LM, Robinson MA, Grilo SA, Lewis SM, Pruett AL, Ickovics JR. Group Prenatal Care Reduces Risk of Preterm Birth and Low Birth Weight: A Matched Cohort Study. Journal Of Women's Health 2018, 28: 17-22. PMID: 30256700, DOI: 10.1089/jwh.2017.6817.Peer-Reviewed Original ResearchConceptsGroup prenatal careLow birth weightPreterm birthPrenatal careBirth weightLow birth weight babiesPropensity scoreIndividual prenatal careBirth weight babiesMatched Cohort StudyPrenatal care visitsClinical practice recommendationsPrenatal care patientsYear of deliveryAdequacy of careVanderbilt University Medical CenterUniversity Medical CenterLarge metropolitan hospitalWeight babiesPerinatal outcomesCare visitsCohort studyCare patientsBirth outcomesPatient adherence
2017
Using direct antiglobulin test results to reduce unnecessary cold agglutinin testing
Wilen CB, Booth GS, Grossman BJ, Lane WJ, Szklarski PC, Jackups R. Using direct antiglobulin test results to reduce unnecessary cold agglutinin testing. Transfusion 2017, 57: 1480-1484. PMID: 28266038, DOI: 10.1111/trf.14059.Peer-Reviewed Original ResearchConceptsNegative direct antiglobulin testDirect antiglobulin testCold agglutinin diseaseMedical CenterCA testingDirect antiglobulin test resultsElevated cold agglutinin titerRare autoimmune hemolytic anemiaPositive direct antiglobulin testCold-reactive autoantibodiesAutoimmune hemolytic anemiaBarnes-Jewish HospitalMajor academic medical centerCold agglutinin titerUniversity Medical CenterVanderbilt University Medical CenterMassachusetts General HospitalAcademic medical centerDAT resultsRetrospective studyGeneral HospitalAntiglobulin testHemolytic anemiaAgglutinin titersPatients
2016
Evaluation of a Prediction Model for the Development of Atrial Fibrillation in a Repository of Electronic Medical Records
Kolek M, Graves A, Xu M, Bian A, Teixeira P, Shoemaker M, Parvez B, Xu H, Heckbert S, Ellinor P, Benjamin E, Alonso A, Denny J, Moons K, Shintani A, Harrell F, Roden D, Darbar D. Evaluation of a Prediction Model for the Development of Atrial Fibrillation in a Repository of Electronic Medical Records. JAMA Cardiology 2016, 1: 1007-1013. PMID: 27732699, PMCID: PMC5293184, DOI: 10.1001/jamacardio.2016.3366.Peer-Reviewed Original ResearchIncident atrial fibrillationElectronic medical recordsCHARGE-AF modelAtrial fibrillationRisk prediction modelMedical recordsEMR cohortHistory of AFInternal medicine outpatient clinicProspective cohort studyDiastolic blood pressureMedicine outpatient clinicIndividuals 40 yearsType 2 diabetesHigh-risk individualsVanderbilt University Medical CenterUniversity Medical CenterLow-risk individualsPoor calibrationAfrican AmericansFuture risk modelsHealth care expendituresAF managementCohort studyEchocardiographic variablesEffect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema
Straka BT, Ramirez CE, Byrd JB, Stone E, Woodard-Grice A, Nian H, Yu C, Banerji A, Brown NJ. Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema. Journal Of Allergy And Clinical Immunology 2016, 140: 242-248.e2. PMID: 27913306, PMCID: PMC5705179, DOI: 10.1016/j.jaci.2016.09.051.Peer-Reviewed Original ResearchConceptsACE inhibitor-associated angioedemaResolution of symptomsVisual analog scaleAnalog scaleReceptor antagonistTreatment groupsBradykinin BEnzyme (ACE) inhibitor-associated angioedemaStudy drug administrationReceptor antagonist icatibantHours of presentationTreatment of attacksC1 inhibitor deficiencyBradykinin receptor antagonismFrequency of administrationVanderbilt University Medical CenterUniversity Medical CenterMassachusetts General HospitalTwo-thirdsAntagonist icatibantBowel edemaWhite patientsH2 blockersClinical efficacyInhibitor deficiencyA long journey to short abbreviations: developing an open-source framework for clinical abbreviation recognition and disambiguation (CARD)
Wu Y, Denny J, Rosenbloom S, Miller R, Giuse D, Wang L, Blanquicett C, Soysal E, Xu J, Xu H. A long journey to short abbreviations: developing an open-source framework for clinical abbreviation recognition and disambiguation (CARD). Journal Of The American Medical Informatics Association 2016, 24: e79-e86. PMID: 27539197, PMCID: PMC7651947, DOI: 10.1093/jamia/ocw109.Peer-Reviewed Original ResearchConceptsClinical NLP systemsOpen-source frameworkNLP systemsClinical corpusClinical abbreviationsClinic visit notesSense inventoryKnowledge Extraction SystemAbbreviation recognitionWord sense disambiguation methodDischarge summariesF1 scoreExternal corpusClinical narrativesSense disambiguation methodSystem capabilitiesVanderbilt University Medical CenterWrapperFrequent abbreviationsDisambiguation methodMetaMapAbbreviation identificationCardsVisit notesDisambiguationHigh-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial
Billings FT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, Brown NJ. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial. JAMA 2016, 315: 877. PMID: 26906014, PMCID: PMC4843765, DOI: 10.1001/jama.2016.0548.Peer-Reviewed Original ResearchMeSH KeywordsAcute Kidney InjuryAgedAged, 80 and overAspartate AminotransferasesAtorvastatinCardiac Surgical ProceduresCreatinineDouble-Blind MethodDrug Administration ScheduleFemaleGlomerular Filtration RateHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMedication AdherenceMiddle AgedPostoperative ComplicationsRenal Insufficiency, ChronicConceptsAcute kidney injuryMorning of surgerySerum creatinine concentrationPlacebo groupCardiac surgeryStatin treatmentAtorvastatin groupKidney injuryClinical trialsCreatinine concentrationAcute Kidney Injury Following Cardiac SurgeryAdult cardiac surgery patientsCardiac surgery patientsChronic kidney diseaseHours of surgeryPostoperative day 2Day of surgerySafety monitoring boardVanderbilt University Medical CenterUniversity Medical CenterAtorvastatin dailyStatin therapyAtorvastatin treatmentSurgery patientsKidney disease
2014
Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality
Xu H, Aldrich M, Chen Q, Liu H, Peterson N, Dai Q, Levy M, Shah A, Han X, Ruan X, Jiang M, Li Y, St Julien J, Warner J, Friedman C, Roden D, Denny J. Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality. Journal Of The American Medical Informatics Association 2014, 22: 179-191. PMID: 25053577, PMCID: PMC4433365, DOI: 10.1136/amiajnl-2014-002649.Peer-Reviewed Original ResearchConceptsType 2 diabetes patientsElectronic health recordsCancer patientsCancer mortalityDiabetes patientsEHR dataNon-diabetic cancer patientsCox proportional hazards modelDrug exposure informationOral hypoglycemic medicationsCharlson Comorbidity IndexNon-diabetic patientsUse of metforminCancer diagnosisHealth recordsSite-specific cancersBody mass indexProportional hazards modelVanderbilt University Medical CenterUniversity Medical CenterLarge electronic health recordHypoglycemic medicationsCause mortalityComorbidity indexInsulin use
2013
Pollen Count and Presentation of Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema
Straka B, Nian H, Sloan C, Byrd JB, Woodard-Grice A, Yu C, Stone E, Steven G, Hartert T, Teo KK, Pare G, McCarty CA, Brown NJ. Pollen Count and Presentation of Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema. The Journal Of Allergy And Clinical Immunology In Practice 2013, 1: 468-473.e4. PMID: 24565618, PMCID: PMC4042396, DOI: 10.1016/j.jaip.2013.05.003.Peer-Reviewed Original ResearchConceptsACE inhibitor-associated angioedemaRate of angioedemaSeasonal allergiesRamipril Global Endpoint TrialAngiotensin converting enzyme (ACE) inhibitorsEnzyme (ACE) inhibitor-associated angioedemaIncidence of angiotensinMonths of presentationAdverse drug eventsDate of presentationVanderbilt University Medical CenterUniversity Medical CenterMarshfield Clinic Personalized Medicine Research ProjectOngoing TelmisartanEndpoint trialsACE inhibitorsPollen countsDrug eventsAssociated angioedemaObservational studyCohort analysisMedical CenterHospital settingAngioedemaPersonalized Medicine Research ProjectThe Effect of Reducing Maximum Shift Lengths to 16 Hours on Internal Medicine Interns’ Educational Opportunities
Theobald CN, Stover DG, Choma NN, Hathaway J, Green JK, Peterson NB, Sponsler KC, Vasilevskis EE, Kripalani S, Sergent J, Brown NJ, Denny JC. The Effect of Reducing Maximum Shift Lengths to 16 Hours on Internal Medicine Interns’ Educational Opportunities. Academic Medicine 2013, 88: 512-518. PMID: 23425987, PMCID: PMC3638874, DOI: 10.1097/acm.0b013e318285800f.Peer-Reviewed Original ResearchConceptsDuty hour restrictionsMaximum shift lengthsInternal medicine internsHour restrictionsVanderbilt University Medical CenterUniversity Medical CenterCommon presenting problemMedicine internsMore patientsUnique patientsInpatient encountersMorning report conferencesMedian numberMedical CenterProgress notesClinical exposureProcedural experienceShift lengthPresenting problemPatientsMore historyHoursExposureAttendanceInterns
2012
Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records
Liu M, Hinz E, Matheny M, Denny J, Schildcrout J, Miller R, Xu H. Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records. Journal Of The American Medical Informatics Association 2012, 20: 420-426. PMID: 23161894, PMCID: PMC3628053, DOI: 10.1136/amiajnl-2012-001119.Peer-Reviewed Original ResearchConceptsAdverse drug reactionsElectronic medical recordsProportional reporting ratioVanderbilt University Medical CenterSpontaneous reporting systemDrug-event pairsDrug reactionsMedical recordsMedication ordersAbnormal laboratory resultsDrug-exposed groupNew adverse drug reactionsUniversity Medical CenterSpecific drug administrationReference standardLaboratory resultsUnexposed groupGamma Poisson ShrinkerMedical CenterPatient harmDrug AdministrationPharmacovigilance measuresBayesian confidence propagation neural networkEarly detectionReporting ratioOptimizing Drug Outcomes Through Pharmacogenetics: A Case for Preemptive Genotyping
Schildcrout J, Denny J, Bowton E, Gregg W, Pulley J, Basford M, Cowan J, Xu H, Ramirez A, Crawford D, Ritchie M, Peterson J, Masys D, Wilke R, Roden D. Optimizing Drug Outcomes Through Pharmacogenetics: A Case for Preemptive Genotyping. Clinical Pharmacology & Therapeutics 2012, 92: 235-242. PMID: 22739144, PMCID: PMC3785311, DOI: 10.1038/clpt.2012.66.Peer-Reviewed Original ResearchConceptsVanderbilt University Medical CenterAdverse eventsPreemptive genotypingPotential adverse eventsUniversity Medical CenterHome patientsPharmacogenetic associationsMedical CenterVariant allelesMedicationsDrug outcomesPatient safetyDrug decision makingRelevant genetic variantsRoutine integrationTarget drugsGenetic variantsOutcomesFrequency of opportunitiesGenotypingSafetyPrescribingPatientsCohortPharmacogenetics
2011
Acute Coronary Syndrome Pathways
Fong PP, Jackson EB, Churchwell KB, Steaban R, Starmer JM, Johnson DC, McNeil JD, Klint ZW, Scalf SL, Parsons CM, Cortez S, Christensen D, French T, McPherson JA. Acute Coronary Syndrome Pathways. Critical Pathways In Cardiology A Journal Of Evidence-Based Medicine 2011, 10: 1-8. PMID: 21562368, DOI: 10.1097/hpc.0b013e318211bb08.Commentaries, Editorials and LettersConceptsTreatment of ACSOutpatient care teamStandardization of careEvidence-based dataVanderbilt University Medical CenterComputerized provider order entry systemUniversity Medical CenterAcademic medical systemProvider order entry systemValue-based careOrder entry systemCare pathwayPatient outcomesCare teamComprehensive carePractice guidelinesMedical CenterPatientsCost of healthcareHealthcare expendituresReimbursement modelsSubstantial proportionCareSyndrome accountsACS
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply